Y-mAbs Therapeutics (YMAB) PT Raised to $26 at BMO Capital
Tweet Send to a Friend
(Updated - March 4, 2024 8:14 AM EST)
BMO Capital analyst Etzer Darout raised the price target on Y-mAbs ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Etzer Darout raised the price target on Y-mAbs ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
